See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875320_2019_VERTEX_PHARMACEUTICALS_INC_MA.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.4302438176223819, 'aggregate_val': 3558639000, 'exp_sum': 6245898000, 'exp_to_value': {'AssetsCurrent': 3843109000, 'IntangibleAssetsNetIncludingGoodwill': 50384000, 'PropertyPlantAndEquipmentNet': 812005000, 'remainder_Assets': 1540400000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000875320, VERTEX PHARMACEUTICALS INC MA
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,843,109,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 50,384,000 |
| 2 | PropertyPlantAndEquipmentNet | 812,005,000 |
| 3 | remainder_Assets | -1,146,859,000 |
| 4 | LiabilitiesCurrent | 1,120,292,000 |
| 5 | LiabilitiesNoncurrent | 26,280,000 |
| 6 | remainder_Liabilities | 664,123,000 |
| 7 | CostOfGoodsAndServicesSold | 409,539,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 557,616,000 |
| 9 | ResearchAndDevelopmentExpense | 1,416,476,000 |
| 10 | remainder_Expenses | -1,458,046,000 |
| 11 | remainder_Revenues | 3,047,597,000 |
| 12 | remainder_NetIncome | -34,909,000 |
| 13 | remainder_ComprehensiveNetIncome | 46,144,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,558,639,000 |
| 1 | Liabilities | 1,810,695,000 |
| 2 | Expenses | 925,585,000 |
| 3 | Revenues | 3,047,597,000 |
| 4 | StockholdersEquity | 1,747,944,000 |
| 5 | NetIncome | 2,087,103,000 |
| 6 | ComprehensiveNetIncome | 2,110,175,000 |
| 7 | BaseVar | 4,711,784,500 |
| 8 | EconomicCapitalRatio | 1.91 |
Edgar->Model Mapping
Feature Distribution
Change over Time
